Related Experiment Video
Updated: Jun 7, 2025

Assays for the Degradation of Misfolded Proteins in Cells
Published on: August 28, 2016
TSG101 depletion dysregulates mitochondria and PML NBs, triggering MAD2-overexpressing interphase cell death (MOID)
Yao Xi1,2, Rui Xu1,2, Shengnan Chen1,2
1National Resource Center for Mutant Mice, MOE Key Laboratory of Model Animals for Disease Study, Model Animal Research Center, Medical School of Nanjing University, Nanjing, 210061, China.
Abstract:
Overexpression of mitotic arrest deficiency 2 (MAD2/MAD2L1), a pivotal component of the spindle assembly checkpoint (SAC), resulted in many types of cancer. Here we show that the depletion of tumor susceptibility gene 101 (TSG101), causes synthetic dosage lethality (SDL) in MAD2-overexpressing cells, and we term this cell death MAD2-overexpressing interphase cell death (MOID). The induction of MOID depends on PML and DAXX mediating mitochondrial AIFM1-release. MAD2, TSG101, and AIF-PML-DAXX axis regulate mitochondria, PML nuclear bodies (NBs), and autophagy with close inter-dependent protein stability in survival cells. Loss of C-terminal phosphorylation(s) of TSG101 and closed (C-)MAD2-overexpression contribute to induce MOID. In survival cells, both MAD2 and TSG101 localize at PML NBs in interphase, and TSG101 Y390 phosphorylation is required for localization of TSG101 to PML NBs. PML release from PML NBs through PML deSUMOylation contributes to induce MOID. The post-transcriptional/translational cell death machinery and the non-canonical transcriptional regulation are intricately linked to MOID, and ER-MAM, may serve as a crucial intersection for MOID signaling.
Insights
Overexpression of mitotic arrest deficiency 2 (MAD2) combined with depletion of tumor susceptibility gene 101 (TSG101) triggers a novel cell death pathway called MOID. This process involves mitochondrial dysfunction and PML nuclear bodies, impacting cancer cell survival.
Area of Science:
- Cell Biology
- Molecular Oncology
- Cancer Research
Background:
- Overexpression of mitotic arrest deficiency 2 (MAD2/MAD2L1), a key spindle assembly checkpoint (SAC) component, is implicated in various cancers.
- The role of tumor susceptibility gene 101 (TSG101) in conjunction with MAD2 overexpression in cancer cell death remains largely unexplored.
Purpose of the Study:
- To investigate the novel cell death mechanism, termed MAD2-overexpressing interphase cell death (MOID), induced by TSG101 depletion in MAD2-overexpressing cancer cells.
- To elucidate the molecular pathways and protein interactions governing MOID, focusing on the roles of PML, DAXX, and mitochondrial signaling.
Main Methods:
- Utilized cell culture models with MAD2 overexpression and TSG101 depletion to induce and study MOID.
- Investigated the involvement of PML, DAXX, AIFM1, and mitochondrial release in MOID induction.
- Analyzed protein localization, stability, phosphorylation, and deSUMOylation of key proteins including MAD2, TSG101, and PML.
Main Results:
- TSG101 depletion causes synthetic dosage lethality (SDL) in MAD2-overexpressing cells, leading to MOID.
- MOID induction is dependent on PML and DAXX-mediated mitochondrial apoptosis-inducing factor 1 (AIFM1) release.
- MAD2, TSG101, and the AIF-PML-DAXX axis regulate mitochondria, PML nuclear bodies (NBs), and autophagy, with interdependent protein stability crucial for cell survival.
- Loss of TSG101 C-terminal phosphorylation and closed (C-)MAD2 overexpression contribute to MOID.
- PML release from NBs via deSUMOylation is critical for MOID induction.
Conclusions:
- MOID represents a novel synthetic dosage lethality pathway triggered by the interplay between MAD2 overexpression and TSG101 loss.
- The AIF-PML-DAXX axis and mitochondrial integrity are central to MOID execution.
- PML nuclear bodies and protein post-translational modifications, including TSG101 phosphorylation and PML deSUMOylation, are critical regulators of this cell death pathway.
More Related Videos
Related Concept Videos
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
DNA Damage can Stall the Cell Cycle
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...

